Since ATX-LPA signaling is implicated in cardiovascular disease, particularly atherosclerosis [54,117], it is tempting to speculate that changes in the ATX-LPA pathway play an important role in promoting cardiovascular disease during obesity/insulin resistance. The gene discussed is ENPP2; the disease is obesity disorder.